Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Laura J. Esserman(University of California, San Francisco), David M. Ota(Southwestern Medical Center), Jeremy Hoog(Washington University in St. Louis), Gary Unzeitig(Doctors Hospital of Laredo), Paula Silverman(Southwestern Medical Center), Pat W. Whitworth(Southwestern Medical Center), Katherine DeSchryver(Washington University in St. Louis), Gildy V. Babiera(The University of Texas MD Anderson Cancer Center), Rodrigo Gonçalves(Southwestern Medical Center), Jingqin Luo(Washington University in St. Louis), Timothy Pluard(Southwestern Medical Center), Matthew J. Ellis(University of California, Davis), Chad J. Creighton(Baylor College of Medicine), Lisa A. Carey(University of North Carolina at Chapel Hill), G. Thomas Budd, Mitch Dowsett(Institute of Cancer Research), Julia Guenther, Mark Watson, Souzan Sanati(Washington University in St. Louis), Eric P. Winer(University of Vermont), Cynthia X. Ma, Amy Brink(Southwestern Medical Center), Vera J. Suman(Mayo Clinic in Arizona), Michael Barnes(European Organization for Nuclear Research), Tao Yu(Soochow University), Erika C. Crouch(Southwestern Medical Center), Marilyn Leitch, D. Craig Allred(The University of Texas Health Science Center at San Antonio), Zoneddy Dayao(University of New Mexico Hospital), John A. Olson(Vanderbilt University), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k